#USA #Life Sciences #Pinnaql #Pharma Resource Group #Royersford, Pennsylvania

Pinnaql Expands Its Expertise with Pharma Resource Group Acquisition

In a strategic move aimed at elevating its service offerings, Pinnaql, Inc. has announced the acquisition of Pharma Resource Group, Inc. (PRG), a recognized consulting firm specializing in support for pharmaceutical and biotechnology sectors in the United States and beyond. This acquisition, which builds on Pinnaql's established partnership with 3 Boomerang Capital, substantially enhances Pinnaql's capabilities in formulation development, technology transfer, and manufacturing advisory services.

As the life sciences landscape continues to evolve, companies are increasingly faced with intricate scientific and regulatory requirements. The integration of PRG into Pinnaql represents a significant step toward creating a more comprehensive one-stop solution for clients looking to navigate these complexities from the early stages of product development through to commercial manufacturing.

Bridging the Gaps in Life Sciences

Pinnaql's CEO, John Duffin, emphasized the importance of an integrated approach to the life sciences development process. He stated, “The best outcomes don’t start at the regulatory filing; they begin in the lab, carry through tech transfer, and are validated on the manufacturing floor.” This statement reflects the company's commitment to providing end-to-end support that is critical for client success.

The addition of PRG's expertise brings a wealth of knowledge in key areas such as analytical sciences and commercial manufacturing, effectively closing the loop in the development cycle. By doing so, Pinnaql offers its clients an unparalleled resource that reduces the need for multiple specialty providers, thereby streamlining project management and enhancing operational efficiency.

A Comprehensive Platform for Clients

Pinnaql has built its platform around four core service areas: Quality Systems Operations, Laboratory Lifecycle, Manufacturing Technical Operations, and Automation/Digital Transformation. With the acquisition of PRG, the company has deepened its capabilities in two significant ways:

1. Broadening with Tech Transfer & Scale-Up: PRG's strong focus on formulation sciences and regulatory readiness will allow Pinnaql to support drug products more effectively as they transition from laboratory development to scalable manufacturing processes. Previously, this often required clients to coordinate between multiple providers, adding complexity to the process.

2. Deepening in Manufacturing & Laboratory Services: PRG's established change control capabilities enhance Pinnaql's ability to assist clients in regulated environments where precision and compliance are essential. This includes managing post-approval changes and preparing for commercial launches, a vital aspect for both biotech innovators and traditional pharmaceutical manufacturers.

John P. Raech, Co-Founder and President of PRG, expressed enthusiasm about the merger, highlighting the advantages for clients: “Joining Pinnaql gives our clients access to a broader set of capabilities—engineering, validation, quality systems, and digital tools—without disrupting the relationships and standards they've come to rely on.”

Driving Innovation in Life Sciences

The acquisition of Pharma Resource Group aligns with Pinnaql’s broader growth strategy as seen in its earlier integration of Validation Engineering Group (VEG). This consolidation reflects Pinnaql's commitment to operating as a full-lifecycle partner, equipped to meet the demands of the pharmaceutical, biotechnology, and contract development and manufacturing organizations (CDMOs).

Together, these organizations will offer specialized support that ensures clients remain compliant with evolving global regulatory expectations, while also delivering technically rigorous solutions that empower innovation.

Pinnaql continues to position itself as a trusted partner in the life sciences sector, delivering quality, regulatory, and operational excellence consulting to biopharmaceutical and medical device companies around the world. With this acquisition, Pinnaql not only expands its footprint but also reinforces its mission to elevate compliance and empower innovation throughout the product lifecycle.

About Pinnaql

Pinnaql is dedicated to providing consulting services in quality, regulatory, and operational excellence to biopharmaceutical and CDMO companies. The firm focuses on delivering compliant solutions that catalyze innovation and enhance human health. For more information, visit www.pinnaql.com.

About Pharma Resource Group, Inc.

Founded in 2007, Pharma Resource Group offers analytical sciences, formulation development, manufacturing advisory, and change control consulting services to the life sciences industries. PRG is known for its commitment to quality and operational readiness, helping clients navigate the complexities of regulatory compliance and achieve their development goals with precision and reliability.